The subdued emergence and limited spread of heavily mutated lineages like BA.3.2, nicknamed Cicada, explain the strong trader consensus against a new COVID variant of concern before 2027. First identified in South Africa in late 2024 and now detected in over 20 countries, this strain shows notable spike-protein changes that could aid immune escape, yet it accounts for under 0.2 percent of U.S. sequences and has not driven notable rises in cases or hospitalizations through early 2026. Dominant circulating strains remain established Omicron subvariants such as XFG.1.1, with global surveillance networks reporting steady but unremarkable evolution and no rapid dominance by any novel lineage in the past year. Ongoing monitoring by health authorities continues to flag potential candidates, but the pattern of gradual adaptation without major public-health shifts supports expectations that the next variant of concern designation will likely occur after 2026.